6-phenylhexyl isothiocyanate has been researched along with Multiple Myeloma in 3 studies
*Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiao, JW; Feng, J; Gallagher, R; Lee, MY; Lin, X; Liu, D; Lu, Q; Zhao, X | 1 |
Hong, XL; Lu, QY; Zhang, ZC; Zhao, JN | 1 |
Liu, DL; Lu, QY; Wang, Z | 1 |
3 other study(ies) available for 6-phenylhexyl isothiocyanate and Multiple Myeloma
Article | Year |
---|---|
Phenylhexyl isothiocyanate has dual function as histone deacetylase inhibitor and hypomethylating agent and can inhibit myeloma cell growth by targeting critical pathways.
Topics: Cell Cycle; Cell Line, Tumor; Cell Proliferation; DNA Methylation; Histone Deacetylase Inhibitors; Histones; Humans; Isothiocyanates; Membrane Potential, Mitochondrial; Multiple Myeloma; ras Proteins; Receptors, Interleukin-6; Vascular Endothelial Growth Factor A | 2008 |
[Inhibitory effect of phenylhexyl isothiocyanate on notch signaling of multiple myeloma cells in vitro].
Topics: Cell Line, Tumor; Humans; Intercellular Signaling Peptides and Proteins; Isothiocyanates; Jagged-2 Protein; Membrane Proteins; Multiple Myeloma; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Receptor, Notch1; Signal Transduction | 2011 |
[Effect of phenylhexyl isothiocyanate on inducing apoptosis of multiple myeloma cells in vitro].
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Humans; Isothiocyanates; Multiple Myeloma; Vascular Endothelial Growth Factor A | 2008 |